Vycor Medical Statistics
Total Valuation
Vycor Medical has a market cap or net worth of 3.84 million. The enterprise value is 4.80 million.
| Market Cap | 3.84M |
| Enterprise Value | 4.80M |
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Vycor Medical has 33.37 million shares outstanding. The number of shares has increased by 1.35% in one year.
| Current Share Class | 33.37M |
| Shares Outstanding | 33.37M |
| Shares Change (YoY) | +1.35% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 0.15% |
| Owned by Institutions (%) | n/a |
| Float | 12.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.27 |
| PB Ratio | -0.99 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 141.54 |
| P/OCF Ratio | 122.56 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 35.64, with an EV/FCF ratio of 177.20.
| EV / Earnings | -10.93 |
| EV / Sales | 2.85 |
| EV / EBITDA | 35.64 |
| EV / EBIT | n/a |
| EV / FCF | 177.20 |
Financial Position
The company has a current ratio of 0.13
| Current Ratio | 0.13 |
| Quick Ratio | 0.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | 7.63 |
| Debt / FCF | 37.91 |
| Interest Coverage | -0.12 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -0.81% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 0.33% |
| Revenue Per Employee | 241,248 |
| Profits Per Employee | -62,789 |
| Employee Count | 7 |
| Asset Turnover | 1.77 |
| Inventory Turnover | 1.04 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.78% in the last 52 weeks. The beta is -0.44, so Vycor Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.44 |
| 52-Week Price Change | +27.78% |
| 50-Day Moving Average | 0.11 |
| 200-Day Moving Average | 0.08 |
| Relative Strength Index (RSI) | 47.91 |
| Average Volume (20 Days) | 3,990 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.58 |
Income Statement
In the last 12 months, Vycor Medical had revenue of 1.69 million and -439,525 in losses. Loss per share was -0.01.
| Revenue | 1.69M |
| Gross Profit | 1.48M |
| Operating Income | -12,419 |
| Pretax Income | -114,958 |
| Net Income | -439,525 |
| EBITDA | 51,981 |
| EBIT | -12,419 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 61,049 in cash and 1.03 million in debt, giving a net cash position of -966,945 or -0.03 per share.
| Cash & Cash Equivalents | 61,049 |
| Total Debt | 1.03M |
| Net Cash | -966,945 |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | -3.89M |
| Book Value Per Share | -0.12 |
| Working Capital | -4.05M |
Cash Flow
In the last 12 months, operating cash flow was 31,314 and capital expenditures -4,199, giving a free cash flow of 27,115.
| Operating Cash Flow | 31,314 |
| Capital Expenditures | -4,199 |
| Free Cash Flow | 27,115 |
| FCF Per Share | 0.00 |
Margins
Gross margin is 87.70%, with operating and profit margins of -0.74% and -6.82%.
| Gross Margin | 87.70% |
| Operating Margin | -0.74% |
| Pretax Margin | -6.81% |
| Profit Margin | -6.82% |
| EBITDA Margin | 3.08% |
| EBIT Margin | -0.74% |
| FCF Margin | 1.61% |
Dividends & Yields
Vycor Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.35% |
| Shareholder Yield | n/a |
| Earnings Yield | -11.45% |
| FCF Yield | 0.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 15, 2013. It was a reverse split with a ratio of 0.0066666.
| Last Split Date | Jan 15, 2013 |
| Split Type | Reverse |
| Split Ratio | 0.0066666 |
Scores
Vycor Medical has an Altman Z-Score of -52.87 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -52.87 |
| Piotroski F-Score | 4 |